Lipid-lowering therapy and risk-based LDL-C goal attainment in Belgium: DA VINCI observational study.
peer reviewed ; ("[en] BACKGROUND: Cardiovascular disease (CVD) is one of the leading causes of death in Belgium. Current strategies for the prevention and management of CVD focus on reducing low-density lipoprotein cholesterol (LDL-C) levels. This analysis assessed whether LDL-C goals, recommended by the European Society of Cardiology (ESC)/European Atherosclerosis Society (EAS) guidelines, were being achieved in a Belgian study population. METHODS: The cross-sectional, observational, DA VINCI study enrolled patients prescribed lipid-lowering therapy (LLT) between 21 June 2017 and 20 November... Mehr ...
Verfasser: | |
---|---|
Dokumenttyp: | journal article |
Erscheinungsdatum: | 2022 |
Verlag/Hrsg.: |
Taylor and Francis Ltd.
|
Schlagwörter: | Cardiovascular disease / cholesterol / diabetes / hypertension / statins / Cardiology and Cardiovascular Medicine / General Medicine / Human health sciences / Endocrinology / metabolism & nutrition / Sciences de la santé humaine / Endocrinologie / métabolisme & nutrition |
Sprache: | Englisch |
Permalink: | https://search.fid-benelux.de/Record/base-26593207 |
Datenquelle: | BASE; Originalkatalog |
Powered By: | BASE |
Link(s) : | https://orbi.uliege.be/handle/2268/296393 |